COLD-FX Immune Plus
Natural health product licensed in Canada
- Other names
- COLD-FX + Immune Multi, COLD-FX + Immune, COLD-FX PLUS Immune, COLD-FX PLUS Immune Multi
- Licence holder
- Bausch & Lomb Inc.
- NPN or DIN-HM
- 80119465
- Status
- Active licence
- Licence date
- 17 June 2022
- Revision date
- 1 December 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax quinquefolius Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 mg | 200 mg | Not calculated |
| Cuivre Source : Citrate de cuivre (II) | 1 mg | 2,000 µg |
| Zinc Source : Citrate de zinc | 15 mg | 30,000 µg |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxychromen-4-one Source : Quercétine dihydraté | 125 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 12.5 microgram | 25 µg |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Used in Herbal Medicine as an adaptogen to help maintain a healthy immune system. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps (to) maintain/support immune function. Helps (to) maintain/support immune function/system. Helps in energy metabolism and in tissue formation. Helps to form red blood cells. Helps to maintain normal iron transport in the body. Helps to prevent copper deficiency. Helps to prevent vitamin D deficiency. Helps with immune function. Maintains good health. Supports good health. Helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system. Helps to increase production of certain types of cytokines that may signal and activate the immune system in high performing athletes. Helps to increase production of certain types of cytokines involved in the immune response in high performing athletes. Provides further reduction of cold and flu symptoms when taken with a flu shot. Further reduces the frequency, severity and duration of cold and flu symptoms when taken with a flu shot. Clinically proven to reduce the frequency, severity and duration of cold and flu symptoms in individuals over 65 by boosting the immune system. Clinically proven to be safe and efficacious against cold and flu symptoms in individuals over 65. COLD-FX is safe and efficacious for reducing symptoms associated with acute respiratory tract infections. COLD-FX helps reduce overall symptoms of sore throat, runny nose, sneezing, nasal congestion, malaise, fever, headache, hoarseness, ear-aches and cough. Helps reduce the frequency (number or occurrence) of symptoms associated with upper respiratory tract infections when taken daily. Helps reduce the frequency (number or occurrence), severity and duration of colds and flu symptoms when taken daily. Helps reduce the frequency of cold and flu symptoms when taken daily. Clinically proven to reduce the frequency, severity and duration of cold and flu symptoms in individuals over 65 by boosting the immune system when taken daily. Clinically proven to be safe and efficacious against cold and flu symptoms in individuals over 65 when taken daily. Helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system when taken daily. Source of antioxidant(s )/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80119465
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging